Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Patent
1998-04-06
1999-09-21
Railey, II, Johnny F.
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
4353201, 435476, 4352523, 536 231, 536 241, C12N 121, C12N 1570, C12N 1574, C12N 1564
Patent
active
059553685
ABSTRACT:
A system is used to express clostridial gene constructions in a clostridial host. A mobilizable transfer plasmid is described which permits the direct transfer of the plasmid, and genes carried on it, from E. coli into Clostridium species. A promoter is described for use in clostridial species. Also, a useful host strain is used which is nontoxigenic and which permits high levels of expression of clostridial genes using the clostridial promoter.
REFERENCES:
T.L. Bannam and J.I. Rood, "Clostridium perfringens--Escherichia coli Shuttle Vectors that Carry Single Antibiotic Resistance Determinants," Plasmid 229:223-235, 1993.
J.E. Brown and E.D. Williamson, "Molecular Approaches to Novel Vaccines for the Control of Clostridial Toxemias and Infections," The Clostridia: Molecular Biology and Pathogenesis, Academic Press, pp. 505-525, 1997.
B. Dupuy and A.L. Sonenshein, "Transcriptional Regulation of Clostridium difficile TOXA and TOXB Genes," p. 58, 1997 (Abstract).
E.A. Johnson and M. Bradshaw, "Genetic Characterization of Neurotoxin Complexes in Clostridium botulinum Type A," p. 39, 1997 (Abstract).
E.A. Johnson, et al., "Characterization of Neurotoxin Mutants in Clostridium botulinum Type A," Clin. Infect. Dis. 25(Suppl 2):S168-S170, 1997.
W.-J. Lin, "Characterization of Toxin--Negative Mutants of Clostridium botulinum 62A Produced by Transposon TN916 Mutagenesis," The Development of Genetic Methods to Study Group I Clostridium botulinum pp. 100-128, 1992.
W.-J. Lin and E.A. Johnson, "Genome Analysis of Clostridium botulinum Type A by Pulsed-Field gel Electrophoresis," App. Env. Micro. 61(12):4441-4447, 1995.
D. Lyras and J.I. Rood, "Conjugative Transfer of PR4-oriT Shuttle Vectors from Escherichia coli to Clostridium perfringens," Plasmid 39:160-164, 1998.
D. Lyras, et al., "Conjugative Transfer of Shuttle and Suicide Vectors From Escherichia coli to Clostridium perfringens," Second International Meeting on the Molecular Genetics and Pathogenesis of the Clostridia, pp. 10, 11 and 73, Jun. 22-Jun. 25, 1997 (Poster).
J. C. Marvaud, et al., "orf21 is a Positive Regulatory of Btulinum Neurotoxin and Associated Non-Toxic Protein Genes in C. botulinum,"p. 59, 1997 (Abstract).
N.P. Minton, "Molecular Genetics of Clostridial Neurotoxins," Department of Molecular Biology, Porton Down, Salisbury, UK, pp. 161-194, 19 .
E.J. Schantz and E.A. Johnson, "Properties and Use of Botulinum Toxin and Other Microbial Neurotoxins in Medicine," Micro. Rev. 56(1):80-99, 1992.
J.A. Schmidt, et al., "Development of a Reporter System to Study Neurotoxin Gene Expression in Clostridium botulinum Type A Strains," 1998.
J. Sloan, et al., "Construction of a Sequenced Clostridium perfringens-Escherichia coli Shuttle Plasmid," Plasmid 27:207-219, 1992.
T.C. Umland, et al., "The Crystal Structure of Tetanus Neurotoxin H.sub.C Fragment," p. 38, 1997 (Abstract).
Bradshaw Marite
Johnson Eric A.
Lyras Dena
Rood Julian I.
Railey II Johnny F.
Wisconsin Alumni Research Foundation
LandOfFree
Expression system for clostridium species does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Expression system for clostridium species, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Expression system for clostridium species will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-79805